Bristol-Myers Squibb Company

Location

New Jersey

Founded

1887-04-10

Risk Signals

10468 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Bristol-Myers Squibb Company

Live alerts from global media, monitored by Business Radar

FERVEX ADULTS RASPBERRY, batch withdrawal

2024-09-06 (vidal.fr)

FERVEX ADULTS RASPBERRY, batch withdrawal

Following the observation, during routine tests, of atypical results on 4 non-marketed batches, all batches of FERVEX ADULTES RASPBERRY granules

Read more
MUCOMYST powder for oral solution: batch recall of sachet and bottle presentations

2024-06-22 (vidal.fr)

MUCOMYST powder for oral solution: batch recall of sachet and bottle presentations

Following the investigations carried out as part of the recall of batches of FERVEX, a recall of batches of MUCOMYST (acetylcysteine) was decided as a precautionary measure.

Read more
MUCOMYST powder for oral solution: batch recall of sachet and bottle presentations

2024-06-22 (vidal.fr)

MUCOMYST powder for oral solution: batch recall of sachet and bottle presentations

Following the investigations carried out as part of the recall of batches of FERVEX, a recall of batches of MUCOMYST (acetylcysteine) was decided as a precautionary measure.

Read more
Bristol-Myers recalls blood pressure drug Avalide

2020-09-17 (reuters.com)

Bristol-Myers recalls blood pressure drug Avalide

Bristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.

Read more
Bristol-Myers recalls blood pressure drug Avalide

2020-09-17 (reuters.com)

Bristol-Myers recalls blood pressure drug Avalide

Bristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.

Read more
Bristol-Myers recalls blood pressure drug Avalide

2020-09-17 (reuters.com)

Bristol-Myers recalls blood pressure drug Avalide

Bristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.

Read more
Under the gun after Opdivo setbacks, Bristol-Myers Squibb names a new chief scientist

2020-08-18 (endpts.com)

Under the gun after Opdivo setbacks, Bristol-Myers Squibb names a new chief scientist

Hot on the heels of a series of painful setbacks for its marquee program for Opdivo, Bristol-Myers Squibb $BMY is bringing in a new chief scientific officer.

Read more
Blister packs of blood thinner Coumadin recalled

2020-06-17 (consumerreports.org)

Blister packs of blood thinner Coumadin recalled

Bristol-Myers Squibb is recalling eight lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change. The company said the recall involves 144,762 units and is precautionary.

Read more
Blister packs of blood thinner Coumadin recalled

2020-06-17 (consumerreports.org)

Blister packs of blood thinner Coumadin recalled

Bristol-Myers Squibb is recalling eight lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change. The company said the recall involves 144,762 units and is precautionary.

Read more
Take note, I-O players. Bristol-Myers to sell Opdivo in China at half-price: report

2018-08-22 (fiercepharma.com)

Take note, I-O players. Bristol-Myers to sell Opdivo in China at half-price: report

After Bristol-Myers Squibb won the first immuno-oncology nod in China for its PD-1 star Opdivo in June, all parties were holding their breath for its price tag. | The benchmark for prices of future immuno-oncology therapies in China is here.

Read more
Wound care giant Convatec prices $1.8B IPO

2016-10-26 (massdevice.com)

Wound care giant Convatec prices $1.8B IPO

Danish wound care and colostomy supply maker ConvaTec today priced an initial public offering that grossed nearly $1.8 billion on the London Stock Exchange. ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, said it put up 33.8% of its shares in the

Read more
Wound care giant Convatec prices $1.8B IPO

2016-10-26 (massdevice.com)

Wound care giant Convatec prices $1.8B IPO

Danish wound care and colostomy supply maker ConvaTec today priced an initial public offering that grossed nearly $1.8 billion on the London Stock Exchange. ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, said it put up 33.8% of its shares in the

Read more

Never miss a headline about Bristol-Myers Squibb Company

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages